CENTOCOR, INC.

ACTIVE

83 Chadwick Dr, 宾夕法尼亚州费拉德尔菲亚县, Pennsylvania, United Stateswww.centocor.comSubsidiary1,200 employees

Part of 强生

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

47.4%

Phase 1

25.0%

Phase 2

25.0%

Trial Status Distribution

Completed

92.1%

Terminated

5.3%

Withdrawn

2.6%

Clinical Trials

Trials sponsored by this organization (76)

A Randomized, Double-blind, Multicenter, Phase 2 Study of a Human Monoclonal Antibody to Human av Integrins (CNTO 95) in Combination With Docetaxel for the First-Line Treatment of Subjects With Metastatic Hormone Refractory Prostate Cancer

Phase 2

Completed

interventional

Apr 2012131 participants

A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis

Phase 3

Completed

interventional

Oct 2010213 participants

A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects

Phase 1

Completed

interventional

Oct 201049 participants

Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Phase 3

Completed

interventional

Sep 2010264 participants

A Study of the Pharmacokinetics of Golimumab in Chinese Male Subjects

Phase 1

Completed

interventional

Sep 201024 participants

A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma

Phase 1

Completed

interventional

Jun 201079 participants

A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid Tumors

Phase 1

Completed

interventional

May 201053 participants

Page 1 of 10

Approvals

No approval data available

News

No news articles found

Back to Organizations